High plasma prolactin is associated with PRL-R and predicts poor prognosis in Chinese postmenopausal women with breast cancer
The plasma PRL level and PRL-R expression in tumor tissue may be prognostic for Chinese postmenopausal women with breast cancer. The inhibition of PRL and PRL-R signaling is a potential therapeutic approach for endocrine therapy in breast cancer.
Authors
- Wen‐He Huang (ORCID: https://orcid.org/0000-0003-4500-4139)
- Lifang He (ORCID: https://orcid.org/0000-0002-5794-2694)
- Peide Liang (ORCID: https://orcid.org/0000-0002-6718-0531)
- Jundong Wu (ORCID: https://orcid.org/0000-0003-0607-8960)
- Yan Hong (ORCID: https://orcid.org/0000-0002-0397-4586)
- Y.-S. Li (ORCID: https://orcid.org/0009-0002-2928-007X)
- Guangsheng Huang (ORCID: https://orcid.org/0000-0002-9909-9973)
- Xiaolong Jin
- Xiaolong Wei
Institutions
- Xiamen University (CN)
- Shantou University (CN)
- Cancer Hospital of Shantou University Medical College (CN)
- The First People's Hospital of Shunde (CN)
- Chaozhou Central Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Indian Journal of Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/ijc.ijc_1018_21
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00